The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Research!American launches 2016 election blog

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

RESEARCH!AMERICA launched its Campaign for Cures 2016 election blog and an online interactive map featuring hundreds of quotes on medical progress from candidates across the political spectrum running for national office.

Managed by former USA Today senior editor and health reporter Janice Lloyd, the blog features election news, survey data, commentary and analysis of presidential and congressional races in key states on topics relevant to medical progress.

Campaign for Cures partners include Pfizer, the Society for Neuroscience, Alzheimer’s Association, PhRMA, American Heart Association, American Cancer Society Cancer Action Network, University of Maryland School of Medicine, The University of Chicago Pritzker School of Medicine, American Public Health Association, American Association for Cancer Research, Cold Spring Harbor Laboratory, EveryLife Foundation for Rare Diseases, The American College of Neuropsychopharmacology, Penn Medicine, The Whitehead Institute and The American Association of Colleges of Pharmacy.

Table of Contents

YOU MAY BE INTERESTED IN

Clinical

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

By Claire Marie Porter and Sara Willa Ernst
Guest Editorial

My introduction to, and lessons learned from, Rick Pazdur

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
By Mikkael A. Sekeres
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account